Erol Göka

1.4k total citations
93 papers, 1.0k citations indexed

About

Erol Göka is a scholar working on Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry. According to data from OpenAlex, Erol Göka has authored 93 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Psychiatry and Mental health, 32 papers in Clinical Psychology and 13 papers in Biological Psychiatry. Recurrent topics in Erol Göka's work include Schizophrenia research and treatment (15 papers), Tryptophan and brain disorders (13 papers) and Bipolar Disorder and Treatment (12 papers). Erol Göka is often cited by papers focused on Schizophrenia research and treatment (15 papers), Tryptophan and brain disorders (13 papers) and Bipolar Disorder and Treatment (12 papers). Erol Göka collaborates with scholars based in Türkiye, Cambodia and United Kingdom. Erol Göka's co-authors include Cebrail Kısa, Çiğdem Aydemir, Sebahat Aksaray, Rabia Nazik Yüksel, Tayfun Uzbay, Ayşe Devrim Başterzi, Kemal Yazıcı, Gülbahar Baştuğ, Asiye Uğraş Dikmen and Güven Özkaya and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and British Journal of Pharmacology.

In The Last Decade

Erol Göka

76 papers receiving 975 citations

Peers

Erol Göka

PMH

CMN

Carolina David Wiener Brazil

Fernanda Pedrotti Moreira Brazil

Dalibor Karlović Croatia

Alma Mihaljević-Peleš Croatia

Aleksandra Rajewska‐Rager Poland

Felipe A. Jain United States

Nóra Eszlári Hungary

Ali Bozkurt Türkiye

Sarah Cohen‐Woods Australia

Mirela Paiva Vasconcelos-Moreno Brazil

Carolina David Wiener Brazil

Erol Göka

455 ×1.4

221 ×0.8

PMH

344 ×1.5

187 ×0.9

186 ×1.2

CMN

Citations per year, relative to Erol Göka Erol Göka (= 1×) peers Carolina David Wiener

Countries citing papers authored by Erol Göka

Since Specialization

Citations

This map shows the geographic impact of Erol Göka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erol Göka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erol Göka more than expected).

Fields of papers citing papers by Erol Göka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erol Göka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erol Göka. The network helps show where Erol Göka may publish in the future.

Co-authorship network of co-authors of Erol Göka

This figure shows the co-authorship network connecting the top 25 collaborators of Erol Göka. A scholar is included among the top collaborators of Erol Göka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erol Göka. Erol Göka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turhan, Turan, et al.. (2024). Plasma G72 protein in schizophrenia: A comparative analysis of drug-naive schizophrenia patients, patients in acute exacerbation and healthy controls. Journal of Psychiatric Research. 178. 8–14. 1 indexed citations

Bozkurt, Veysel, et al.. (2023). The Mental Health of a Society in Crisis: Complaints of Depression and Anxiety. İstanbul Üniversitesi Sosyoloji Dergisi / İstanbul University Journal of Sociology. 42(3). 153–170. 2 indexed citations

Turhan, Turan, et al.. (2023). Neutrophil gelatinase-associated lipocalin (NGAL) and inflammatory markers in schizophrenia: A comparative analysis of drug-naive schizophrenia patients, remitted patients, and healthy controls. Journal of Psychiatric Research. 169. 14–21. 4 indexed citations

Göka, Erol, et al.. (2023). Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α (TNF-α) levels in patients with schizophrenia. Psychopharmacology. 240(5). 1091–1101. 3 indexed citations

Erzın, Gamze, et al.. (2020). Evaluation of dsyfunctional attitudes, distress and discomfort tolerance levels in patients with premenstruel dysphoric disorder. SHILAP Revista de lepidopterología.

Erzın, Gamze, Güven Özkaya, Rabia Nazik Yüksel, et al.. (2020). Thiol/Disulfide Homeostasis in Bipolar and Unipolar Depression. Clinical Psychopharmacology and Neuroscience. 18(3). 395–401. 8 indexed citations

Yüksel, Rabia Nazik, et al.. (2020). Galectin-1 and Galectin-3 Levels in Patients with Schizophrenia and their Unaffected Siblings. Psychiatric Quarterly. 91(3). 715–725. 6 indexed citations

Yaylacı, Elif Tatlıdil, et al.. (2018). A case of stuttering due to olanzapine treatment. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 31(4). 405–408. 3 indexed citations

Köse, Samet, et al.. (2018). The relationship between internalized stigma and treatment motivation, perceived social support, depression and anxiety levels in opioid use disorder. Psychiatry and Clinical Psychopharmacology. 28(4). 394–401. 29 indexed citations

10.

Göka, Erol, et al.. (2018). Psycho-social Factors that Lead to Heroin Addiction among Young Males in Turkey. Addicta The Turkish Journal on Addictions. 5(3). 577–595. 1 indexed citations

11.

Yılmaz, Fatma, et al.. (2017). Thiol/disulphide homeostasis in men with heroin addiction. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 95–100. 5 indexed citations

12.

Yüksel, Rabia Nazik, et al.. (2016). A delusional parasitosis case responding to low dose risperidone treatment. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 266–270.

13.

Erzın, Gamze, et al.. (2016). Psychosis and mega cisterna magna: Case report. European Psychiatry. 33. 1 indexed citations

14.

Kaymak, Semra Ulusoy, et al.. (2015). Premorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?. Nöro Psikiyatri Arşivi. 52(3). 303–308. 1 indexed citations

15.

Ak, Mehmet, et al.. (2014). Şizofreni Tanılı Hastalarda Prolaktini Yükselten ve Az Etkileyen Antipsikotiklerin Prolaktin Seviyesi ve Kemik Mineral Yoğunluğu Üzerine Etkileri. Nöro Psikiyatri Arşivi. 51(3). 205–210. 8 indexed citations

16.

Yorulmaz, Orçun, A. Nuray Karancı, Gülay Di̇ri̇k, et al.. (2007). Padua Envanteri- Washington Eyalet Üniversitesi Revizyonu: Türkçe Versiyonunun Psikometrik Özellikleri. 10(20). 75–85. 9 indexed citations

17.

Aydemir, Çiğdem, et al.. (2004). Hekimlerin konversiyon bozukluğuna yaklaşımını etkileyen faktörler. Journal of Clinical Psychiatry. 7(2). 73–79. 1 indexed citations

18.

Zincir, Selma Bozkurt, et al.. (2003). Şizofreni hastalarında aile ortamı ve duygu dışavurumunun değerlendirilmesi. Journal of Clinical Psychiatry. 6(4). 198–203. 3 indexed citations

19.

Göka, Erol, et al.. (2002). Ülkemizdeki Ruh Sağlığı Hizmetlerinin Örgütlenme Sorunları ve Bazı Öneriler. 3(2). 80–92.

20.

Göka, Erol. (1999). Bir Semptom Florası ve Dil Olarak Beden. 1(1). 7–17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact